Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000950170-24-109133

Director bought 5,000 shares at $5.29 ($26,450)

From the SEC's structured data for this filing

Trades in this filing

Klencke Barbara · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-09-23 Purchase : show line 1 in the form +5,000 $5.29 $26,450 45,000 D
Open-market purchases · 5,000 sh · avg $5.29 · $26,450
Loading xslF345X05/ownership.xml…